Page 94 - Read Online

Thomas et al. J Transl Genet Genom 2024;8:249-77 https://dx.doi.org/10.20517/jtgg.2024.15 Page 271

compared to lymph node status and tumor stage. Cell Oncol 2007;29:387-98. DOI PubMed PMC
94. Almangush A, Alabi RO, Troiano G, et al. Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review
and meta-analysis. BMC Cancer 2021;21:480. DOI PubMed PMC
95. He R, Li D, Liu B, et al. The prognostic value of tumor-stromal ratio combined with TNM staging system in esophagus squamous
cell carcinoma. J Cancer 2021;12:1105-14. DOI PubMed PMC
96. Zhu Y, Jin Z, Qian Y, Shen Y, Wang Z. Prognostic value of tumor-stroma ratio in rectal cancer: a systematic review and meta-
analysis. Front Oncol 2021;11:685570. DOI PubMed PMC
97. Ruder S, Gao Y, Ding Y, et al. Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer
prognosis. Hum Pathol 2022;122:84-91. DOI PubMed PMC
98. Ayala G, Tuxhorn JA, Wheeler TM, et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. Clin
Cancer Res 2003;9:4792-801. PubMed
99. Tran LL, Dang T, Thomas R, Rowley DR. ELF3 mediates IL-1α induced differentiation of mesenchymal stem cells to inflammatory
iCAFs. Stem Cells 2021;39:1766-77. DOI PubMed PMC
100. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression
of initiated human prostatic epithelium. Cancer Res 1999;59:5002-11. DOI PubMed PMC
101. Hayashi N, Cunha GR. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma.
Cancer Res 1991;51:4924-30. PubMed
102. Proia DA, Kuperwasser C. Stroma: tumor agonist or antagonist. Cell Cycle 2005;4:1022-5. DOI
103. Mun JY, Leem SH, Lee JH, Kim HS. Dual relationship between stromal cells and immune cells in the tumor microenvironment.
Front Immunol 2022;13:864739. DOI PubMed PMC
104. Sanjabi S, Oh SA, Li MO. Regulation of the immune response by TGF-β: from conception to autoimmunity and infection. Cold
Spring Harb Perspect Biol 2017;9:a022236. DOI PubMed PMC
105. Zhang F, Wang H, Wang X, et al. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-
inflammatory phenotype. Oncotarget 2016;7:52294-306. DOI PubMed PMC
106. Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns
Trauma 2012;2:18-28. DOI
107. Zhang Y, Alexander PB, Wang XF. TGF-β family signaling in the control of cell proliferation and survival. Cold Spring Harb
Perspect Biol 2017;9:a022145. DOI PubMed PMC
108. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009;19:156-72. DOI PubMed
PMC
109. Farooq M, Khan AW, Kim MS, Choi S. The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells
2021;10:3242. DOI PubMed PMC
110. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell
Biochem 1991;45:319-26. DOI
111. Diller RB, Tabor AJ. The role of the extracellular matrix (ECM) in wound healing: a review. Biomimetics 2022;7:87. DOI PubMed
PMC
112. Rodriguez-Pascual F, Rosell-Garcia T. Lysyl oxidases: functions and disorders. J Glaucoma 2018;27 Suppl 1:S15-9. DOI PubMed
113. Wang LC, Lo A, Scholler J, et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can
inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res 2014;2:154-66. DOI PubMed PMC
114. Nissen NI, Karsdal M, Willumsen N. Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer
biology. J Exp Clin Cancer Res 2019;38:115. DOI PubMed PMC
115. Henke E, Nandigama R, Ergün S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front Mol
Biosci 2019;6:160. DOI PubMed PMC
116. Hughes CC. Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 2008;15:204-9. DOI PubMed PMC
117. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc Health Risk Manag 2006;2:213-9. DOI PubMed
PMC
118. Li Y, Zhao L, Li XF. Hypoxia and the tumor microenvironment. Technol Cancer Res Treat 2021;20:15330338211036304. DOI
PubMed PMC
119. Zhang Y, Coleman M, Brekken RA. Perspectives on hypoxia signaling in tumor stroma. Cancers 2021;13:3070. DOI PubMed
PMC
120. Crola Da Silva C, Lamerant-Fayel N, Paprocka M, et al. Selective human endothelial cell activation by chemokines as a guide to cell
homing. Immunology 2009;126:394-404. DOI PubMed PMC
121. Crowley T, Buckley CD, Clark AR. Stroma: the forgotten cells of innate immune memory. Clin Exp Immunol 2018;193:24-36. DOI
PubMed PMC
122. Jiang Z, Zhou J, Li L, et al. Pericytes in the tumor microenvironment. Cancer Lett 2023;556:216074. DOI
123. Thomas H, Cowin AJ, Mills SJ. The importance of pericytes in healing: wounds and other pathologies. Int J Mol Sci 2017;18:1129.
DOI PubMed PMC
124. Paiva AE, Lousado L, Guerra DAP, et al. Pericytes in the premetastatic niche. Cancer Res 2018;78:2779-86. DOI PubMed PMC
125. Kirk T, Ahmed A, Rognoni E. Fibroblast memory in development, homeostasis and disease. Cells 2021;10:2840. DOI PubMed
PMC